163 related articles for article (PubMed ID: 31883956)
21. Growth differentiation factor 15: an additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects?
Norozi K; Buchhorn R; Yasin A; Geyer S; Binder L; Seabrook JA; Wessel A
Am Heart J; 2011 Jul; 162(1):131-5. PubMed ID: 21742099
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
Wang H; Chen Q; Li Y; Jing X; Yang J
Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
Fluschnik N; Ojeda F; Zeller T; Jørgensen T; Kuulasmaa K; Becher PM; Sinning C; Blankenberg S; Westermann D
PLoS One; 2018; 13(5):e0197497. PubMed ID: 29771963
[TBL] [Abstract][Full Text] [Related]
25. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
26. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
[TBL] [Abstract][Full Text] [Related]
27. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
[TBL] [Abstract][Full Text] [Related]
28. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.
Mueller T; Leitner I; Egger M; Haltmayer M; Dieplinger B
Clin Chim Acta; 2015 May; 445():155-60. PubMed ID: 25850080
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic usefulness of N-terminal pro-brain natriuretic peptide among children with heart failure in a tertiary hospital in Lagos, Nigeria.
Ekure EN; Okoromah CA; Ajuluchukwu JN; Mbakwem A; Oladipo OO
West Afr J Med; 2011; 30(1):29-34. PubMed ID: 21863586
[TBL] [Abstract][Full Text] [Related]
30. Cystatin C and body surface area are major determinants of the ratio of N-terminal pro-brain natriuretic peptide to brain natriuretic peptide levels in children.
Kurishima C; Masutani S; Kuwata S; Iwamoto Y; Saiki H; Ishido H; Tamura M; Senzaki H
J Cardiol; 2015 Aug; 66(2):175-80. PubMed ID: 25498945
[TBL] [Abstract][Full Text] [Related]
31. Cardiac biomarkers in children with congenital heart disease.
Sugimoto M; Kuwata S; Kurishima C; Kim JH; Iwamoto Y; Senzaki H
World J Pediatr; 2015 Nov; 11(4):309-15. PubMed ID: 26454435
[TBL] [Abstract][Full Text] [Related]
32. Growth-differentiation factor-15 improves reclassification for the diagnosis of heart failure with normal ejection fraction in morbid obesity.
Baessler A; Strack C; Rousseva E; Wagner F; Bruxmeier J; Schmiedel M; Riegger G; Lahmann C; Loew T; Schmitz G; Fischer M
Eur J Heart Fail; 2012 Nov; 14(11):1240-8. PubMed ID: 22843563
[TBL] [Abstract][Full Text] [Related]
33. The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -.
Sugimoto M; Manabe H; Nakau K; Furuya A; Okushima K; Fujiyasu H; Kakuya F; Goh K; Fujieda K; Kajino H
Circ J; 2010 May; 74(5):998-1005. PubMed ID: 20378998
[TBL] [Abstract][Full Text] [Related]
34. The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction.
Stahrenberg R; Edelmann F; Mende M; Kockskämper A; Düngen HD; Lüers C; Binder L; Herrmann-Lingen C; Gelbrich G; Hasenfuss G; Pieske B; Wachter R
Eur J Heart Fail; 2010 Dec; 12(12):1309-16. PubMed ID: 20837635
[TBL] [Abstract][Full Text] [Related]
35. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
[TBL] [Abstract][Full Text] [Related]
36. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.
Santema BT; Chan MMY; Tromp J; Dokter M; van der Wal HH; Emmens JE; Takens J; Samani NJ; Ng LL; Lang CC; van der Meer P; Ter Maaten JM; Damman K; Dickstein K; Cleland JG; Zannad F; Anker SD; Metra M; van der Harst P; de Boer RA; van Veldhuisen DJ; Rienstra M; Lam CSP; Voors AA
Clin Res Cardiol; 2020 Mar; 109(3):331-338. PubMed ID: 31263996
[TBL] [Abstract][Full Text] [Related]
37. GDF-15 (Growth Differentiation Factor 15) Is Associated With Hospitalization and Mortality in Patients With a Fontan Circulation.
Meyer SL; Wolff D; Ridderbos FS; Eshuis G; Hillege H; Willems TP; Ebels T; van Melle JP; Berger RMF
J Am Heart Assoc; 2020 May; 9(10):e015521. PubMed ID: 32384007
[TBL] [Abstract][Full Text] [Related]
38. Sensitive Cardiac Troponins: Could They Be New Biomarkers in Pediatric Pulmonary Hypertension Due to Congenital Heart Disease?
Kayali S; Ertugrul I; Yoldas T; Kaya O; Ozgür S; Orün UA; Karademir S
Pediatr Cardiol; 2018 Apr; 39(4):718-725. PubMed ID: 29340731
[TBL] [Abstract][Full Text] [Related]
39. Growth differentiation factor 15 in different stages of heart failure: potential screening implications.
Wang F; Guo Y; Yu H; Zheng L; Mi L; Gao W
Biomarkers; 2010 Dec; 15(8):671-6. PubMed ID: 20860541
[TBL] [Abstract][Full Text] [Related]
40. N-terminal pro-brain natriuretic peptide levels in patients with anomalous left coronary artery from pulmonary artery.
Yunfei L; Qiang F; Yue W; Yongjun Q
J Cardiothorac Surg; 2020 Jan; 15(1):15. PubMed ID: 31931857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
